Skip to content
WeighLab
Menu
Ranked #143 · Grade C

Boston Medical Group review

Established medical group offering a 3-month semaglutide weight loss program.

Visit Boston Medical Group Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$66/mo (starting dose, compounded)
Tirzepatide
Not disclosed
Coverage
7 states
Brand-name
Compounded only

Semaglutide · modeled / year

$792

The Index scorecard

Boston Medical Group scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month74/100
Price Transparency78/100
Nationwide Access42/100
Formulation Options53/100
Clinical Oversight88/100
Contract Flexibility55/100

Where the value is

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The tradeoffs

  • Limited public information on program details

The bottom line

Best for: Cost-first shoppers who want budget-conscious shoppers. Established medical group offering a 3-month semaglutide weight loss program.

Ranked #143 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Boston Medical Group.

The 18 programs nearest this one

Pricing, states and verification reflect Boston Medical Group's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Boston Medical Group's site. Not medical advice; see our disclosure.

← Back to the value leaderboard